Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.
about
Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri LankaDevelopment of a Japanese encephalitis virus-like particle vaccine in silkworms using codon-optimised prM and envelope genes.Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, doubleImmunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic reviewComparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.Recombinant Measles AIK-C Vaccine Strain Expressing the prM-E Antigen of Japanese Encephalitis Virus.Comparison of the replication characteristics of vaccinia virus strains Guang 9 and Tian Tan in vivo and in vitro.Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Zika Virus Vaccines: Challenges and Perspectives
P2860
Q28397177-FD87E586-519E-4843-B8A9-FE91E54AAE2AQ33561655-BD3CDD6E-AF92-4B5B-A671-A7EE0EBA8CDAQ34976644-54DEE214-F9FD-4954-AA73-14D0F8E0E656Q35558900-A3C25099-3C27-4942-B2D4-7E4BE6625B13Q35886942-4D1300B8-384F-4B03-B061-FA01C69C5B67Q35941078-CFD9B268-C71E-41E0-85C6-FFB6751C9C87Q38993999-17BE84E7-FA4E-4662-9406-FD871B82CEF5Q39181962-57C11843-53E5-4816-8FB3-7D2ED48C068FQ58742686-6DFA0255-FDED-40A6-A3B4-C9B8CB097F06
P2860
Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase III clinical trials comp ...... by using the Beijing-1 strain.
@en
Phase III clinical trials comp ...... by using the Beijing-1 strain.
@nl
type
label
Phase III clinical trials comp ...... by using the Beijing-1 strain.
@en
Phase III clinical trials comp ...... by using the Beijing-1 strain.
@nl
prefLabel
Phase III clinical trials comp ...... by using the Beijing-1 strain.
@en
Phase III clinical trials comp ...... by using the Beijing-1 strain.
@nl
P2093
P2860
P921
P356
P1476
Phase III clinical trials comp ...... by using the Beijing-1 strain.
@en
P2093
Chiaki Miyazaki
Hiroyuki Yokote
Kaneshige Iribe
Kenji Okada
Kohji Ueda
Mizuo Hirose
Takao Ozaki
Takehiro Togashi
Yuji Ishikawa
P2860
P304
P356
10.1128/CVI.00377-13
P577
2013-12-11T00:00:00Z